Mukka Proteins Surges on Revenue but Faces Profit Slump, Customs Duty Demand

AGRICULTURE
Whalesbook Logo
AuthorSimar Singh|Published at:
Mukka Proteins Surges on Revenue but Faces Profit Slump, Customs Duty Demand
Overview

Mukka Proteins reported a stellar Q3 FY26 with consolidated revenue soaring 115.6% YoY to ₹6,534.97 million. However, consolidated PAT grew only 3.7% to ₹272.53 million, while standalone PAT dipped 25.3%. Adding to concerns, the Customs Department issued a ₹176.70 million duty demand. The company also advanced strategic acquisitions to bolster its protein businesses.

📉 The Financial Deep Dive

  • The Numbers: Mukka Proteins Limited posted a commanding Q3 FY26 with consolidated revenue from operations surging by 115.6% year-on-year to ₹6,534.97 million (from ₹3,031.52 million in Q3 FY25). Consolidated Profit After Tax (PAT) saw a modest increase of 3.7% YoY to ₹272.53 million (from ₹262.91 million). On a standalone basis, revenue grew by 94.6% YoY to ₹5,582.64 million, but PAT experienced a significant 25.3% decline, falling to ₹187.59 million from ₹251.02 million in the prior year. For the nine months ended December 31, 2025, consolidated revenue stood at ₹10,688.52 million with a consolidated PAT of ₹357.27 million.

  • The Quality: The substantial disparity between revenue growth and PAT growth, particularly the standalone PAT contraction, indicates considerable margin compression during the quarter. This suggests that cost pressures or other operational inefficiencies outpaced revenue gains, impacting profitability despite increased sales volumes.

  • The Grill: The most pressing issue highlighted is a Bond Enforcement Order from the Customs Department in Mangaluru, demanding customs duty of ₹176.70 million plus applicable interest. This arises from alleged non-submission of Export Obligation Discharge Certificates under the Advance Authorisation Scheme. Furthermore, the company has deferred its proposed acquisition of Mukka Proteins Vietnam Co., Ltd. to June 30, 2026, pending regulatory approvals, adding a layer of strategic uncertainty. Crucially, no specific forward-looking guidance was provided in the announcement, leaving investors to gauge future performance based on current trends and strategic actions.

🚩 Risks & Outlook

  • Specific Risks: The ₹176.70 million customs duty demand presents a significant contingent liability and potential financial strain if upheld. Execution risks associated with integrating newly acquired subsidiaries (United Gulf Fishery Products LLC and the increased stake in Ocean Proteins Private Limited) and the uncertainty surrounding the deferred Vietnam acquisition also pose challenges. The implied margin compression needs close monitoring.

  • The Forward View: Investors will keenly watch the company's response and resolution of the customs duty dispute. The successful integration of acquired entities and their contribution to profitability will be critical. The lack of forward guidance means market sentiment will likely hinge on immediate operational performance and management's ability to navigate the regulatory challenge and leverage strategic expansions effectively.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.